Mycosis Fungoides
📧 Sign up to get email alerts when something new happens for Mycosis Fungoides.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides [Phase 2]
A Phase 2 clinical trial is evaluating ultra-low-dose radiation therapy for patients with Mycosis fungoides, including localized skin lesion…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of VG712 in Patients With Mycosis Fungoides [Phase 2]
Phase 2 study update for VG712 in mycosis fungoides; the trial is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and in combination with ipilimumab, nivolumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers [Phase 2]
This Phase 2 clinical trial update evaluates the combination of talimogene laherparepvec (T-VEC) and nivolumab for patients with refractory …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma [Phase 1]
This clinical trial update discusses MEDI-570, an anti-ICOS monoclonal antibody, in relapsed or refractory peripheral T-cell lymphoma follic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]
Phase 1 clinical trial evaluating the combination of duvelisib and nivolumab for stage IIb–IVB mycosis fungoides and Sézary syndrome; trial …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma [Phase 1]
A Phase 1 clinical trial is evaluating intravenous vesicular stomatitis virus in patients with peripheral T-cell lymphoma and related condit…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides [Phase 1]
This clinical trial update describes a Phase 1 study evaluating mogamulizumab and brentuximab vedotin in patients with cutaneous T-cell lymp…
-
EMA approval · 2026-04-08EMA Authorised: Poteligeo (mogamulizumab) — Kyowa Kirin Holdings B.V.
The EMA authorised Poteligeo (mogamulizumab) for Sezary Syndrome and Mycosis Fungoides. The designation includes orphan medicine status and …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients [Phase 2]
A Phase 2 trial update describes dosing of Brentuximab Vedotin for patients with Mycosis fungoides and Sézary syndrome, with lymphomatoid pa…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL [Phase 3]
A Phase 3 confirmatory study of topical HyBryte versus placebo for cutaneous T-cell lymphoma (CTCL) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab in combination with gemcitabine in adults with advanced mycosis fungoides or Sézary s…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) [EARLY_Phase 1]
The PLIGHT trial, studying phototherapy combined with mogamulizumab in early-stage mycosis fungoides, has been suspended.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) [Phase 1]
A Phase 1 clinical trial is evaluating CCR4-directed CAR T cells in CCR4-expressing mature T-cell malignancies, including peripheral T-cell …
-
FDA approval · 2026-02-19FDA Approved: POTELIGEO — Supplemental Application (Kyowa Kirin, Inc.)
The FDA approved a supplemental application for POTELIGEO (mogamulizumab-kpkc) by Kyowa Kirin, Inc.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome [Phase 1]
A Phase 1 clinical trial evaluating Tulmimetostat (DZR123) in patients with mycosis fungoides and Sézary syndrome; the study is currently ac…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light [Phase 2]
Phase 2 trial evaluating hypericin ointment with visible light for mycosis fungoides has completed.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides [Phase 1]
Phase 1 trial evaluating the safety of combining Bexarotene with radiotherapy in patients with Mycosis Fungoides, a form of cutaneous T-cell…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
The update describes a clinical trial evaluating long-term outcomes in juvenile-onset mycosis fungoides and lymphomatoid papulosis, which is…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) [Phase 2]
Phase 2 clinical trial update for brentuximab vedotin (SGN-35) in CD30-positive lymphoproliferative disorders, including primary cutaneous a…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides [Phase 2]
Phase 2 clinical trial evaluating the combination of ultra-low-dose total-skin electron beam therapy with Brentuximab Vedotin given quarterl…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Romidepsin [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pembrolizumab in combination with romidepsin for recurrent or refractory T-cell lymphomas; the study i…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphoma, …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]
Phase 1 study of CAR-T cells targeting CD30 and CCR4 for relapsed/refractory CD30+ Hodgkin lymphoma and cutaneous T-cell lymphoma, with the …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This clinical trial update indicates ongoing recruitment for a University of Pittsburgh study collecting blood, urine, and tissue samples fr…